Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Foamix Pharmaceuticals
FOMX

Buy Foamix Pharmaceuticals (FOMX) Stock

FOMX
See FOMX stock price and Buy/Sell Foamix Pharmaceuticals with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
FOMX

Foamix Pharmaceuticals (FOMX)

About Foamix Pharmaceuticals (FOMX)

VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate....Read more
Market Cap
$184.14M
1 Year High
$4.84
Volume
1 Year Low
$1.97
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch FOMX stock

Foamix Pharmaceuticals Stock News

Foamix Pharmaceuticals stock rating

What analysts recommend for FOMX stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1

Foamix Pharmaceuticals price target

What analysts think FOMX will be worth
Low $0
High $15
Current $0
Target $15

Foamix Pharmaceuticals earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.12
-0.23
-0.35
Q1 2020
Q2 2020
Q3 2020
Q4 2020

Expected EPS
Q4 2020
-$0.18
Actual EPS
Q4 2020

Buy Foamix Pharmaceuticals (FOMX) Stock

FOMX
See FOMX stock price and Buy/Sell Foamix Pharmaceuticals with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch FOMX stock
  • jeffb3348 avatar
  • BrianDC avatar
  • gwalker99 avatar
  • alphabetpublic avatar
  • buzse avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.